Molecular Imaging: Page 25

Which evidence-based indications point to the use of PET/CT?

By Philip Ward

A multidisciplinary team of U.K. experts has produced a comprehensive guide to help determine when the clinical use of PET/CT is justified. The 86-page document can be downloaded free of charge.

August 7, 2022

EANM committees seek new members

By AuntMinnieEurope.com staff writers

Several committees within the European Association of Nuclear Medicine (EANM) have issued a call for members who have a varied background and range of expertise.

August 4, 2022

Radiopharm collaborates with Lantheus on theranostic agent

By AuntMinnieEurope.com staff writers

Radiopharm Theranostics has entered a collaboration agreement with Lantheus to develop NM-01, a nanobody that can be labeled with radioisotopes to diagnose and treat tumors for theranostic applications.

August 4, 2022

CereMark touts new patents for PET Alzheimer's agent

By AuntMinnieEurope.com staff writers

Radiopharmaceutical developer CereMark announced that additional patents have been awarded to the University of California, Los Angeles for a PET agent that the company licensed from the university for the imaging of Alzheimer's disease.

August 3, 2022

PET imaging to be used in Alzheimer's clinical trials

By AuntMinnieEurope.com staff writers

A New Jersey Health System is leading three clinical trials with the goal of addressing and improving knowledge gaps in treatment and diagnosis of Alzheimer's disease, using amyloid PET imaging.

July 31, 2022

Life Molecular signs Neuraceq deal in the Balkans

By AuntMinnieEurope.com staff writers

Life Molecular Imaging has signed a licensing deal with Biokosmos that gives the company rights to make and distribute the radiopharmaceutical Neuraceq in the Balkans.

July 21, 2022

Subtle Medical expands partnership with Incepto

By AuntMinnieEurope.com staff writers

Artificial intelligence (AI) software developer Subtle Medical has formed a new partnership with European AI platform provider Incepto.

July 18, 2022

Ringertz: Nobel prize for PET may lie on the horizon

VIENNA - A Nobel prize for PET imaging could well be on the cards in the years ahead, but identifying the most deserving recipient(s) is no simple task, Prof. Hans Ringertz revealed during ECR 2022.

July 18, 2022

ECR: Naples team highlights PET/MRI's clinical promise in breast cancer

By Will Morton

Hybrid PET/MRI is a new frontier for breast imaging, as it allows a comprehensive tumor assessment, from morphology to functional properties, according to research shown at ECR 2022 in Vienna.

July 13, 2022

Curium submits F-18 DCFPyL for EU clearance

By AuntMinnieEurope.com staff writers

Nuclear medicine vendor Curium has submitted a marketing authorization application to the European Medicines Agency for clearance to market the PET radiotracer F-18 DCFPyL for diagnosing prostate cancer.

July 7, 2022

PET/CT compares well with MRI for prostate cancer detection

By Kate Madden Yee

Prostate-specific membrane antigen-PET/CT imaging is comparable to MRI for detecting clinically significant prostate cancer. But MRI is still the more accurate modality for determining the grade of disease, according to the results of a new study.

July 6, 2022

EANM, EFOMP to revise curriculum for medical physics experts

By AuntMinnieEurope.com staff writers

The European Association of Nuclear Medicine (EANM) and the European Federation of Organisations for Medical Physics (EFOMP) are collaborating to revise the joint core curriculum for Medical Physics Experts (MPE) working in nuclear medicine.

July 5, 2022

Previous Page

Page 25 of 121

Next Page